Blue Trust Inc. trimmed its stake in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 25.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,255 shares of the real estate investment trust’s stock after selling 2,761 shares during the quarter. Blue Trust Inc.’s holdings in Healthpeak Properties were worth $167,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. AMF Tjanstepension AB bought a new position in shares of Healthpeak Properties during the third quarter valued at about $15,548,000. Creative Planning purchased a new position in shares of Healthpeak Properties in the third quarter worth about $4,390,000. Bleakley Financial Group LLC purchased a new position in shares of Healthpeak Properties in the third quarter worth about $240,000. Raymond James & Associates purchased a new position in shares of Healthpeak Properties in the third quarter worth about $25,711,000. Finally, Allspring Global Investments Holdings LLC purchased a new position in Healthpeak Properties during the third quarter valued at approximately $794,000. 93.57% of the stock is owned by institutional investors.
Healthpeak Properties Stock Up 1.5 %
NYSE:DOC opened at $19.79 on Friday. The firm has a market cap of $13.84 billion, a P/E ratio of 56.53, a P/E/G ratio of 2.15 and a beta of 1.15. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. Healthpeak Properties, Inc. has a fifty-two week low of $16.01 and a fifty-two week high of $23.26. The firm has a 50-day simple moving average of $20.22 and a two-hundred day simple moving average of $21.40.
Healthpeak Properties Increases Dividend
Wall Street Analyst Weigh In
Several equities analysts recently commented on DOC shares. Morgan Stanley raised shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective for the company in a research note on Wednesday, January 15th. Mizuho lowered their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Wells Fargo & Company lowered their price target on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a report on Tuesday, December 10th. StockNews.com lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. Finally, Wedbush reduced their price objective on shares of Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a research report on Friday, February 14th. One analyst has rated the stock with a sell rating, three have issued a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $24.00.
Read Our Latest Report on Healthpeak Properties
Healthpeak Properties Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More
- Five stocks we like better than Healthpeak Properties
- What is an Earnings Surprise?
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- What to Know About Investing in Penny Stocks
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Are Penny Stocks a Good Fit for Your Portfolio?
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.